ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, ...
Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer
Est. EPS $10.60 · Revenue $8.13B · 10 analysts
Est. EPS $3.02 · Revenue $2.10B · 3 analysts
Est. EPS $3.20 · Revenue $2.13B · 6 analysts
Est. EPS $11.94 · Revenue $8.43B · 10 analysts
EPS $0.94 · Revenue $2.06B
EPS $1.36 · Revenue $2.03B
EPS $2.90 · Revenue $8.25B
EPS $0.03 · Revenue $2.04B
EPS $2.30 · Revenue $2.02B
EPS $1.90 · Revenue $2.00B
| Metric | Latest | YoYYoY means Year-over-Year. It compares the latest annual value with the previous annual value to show long-term trend strength. | QoQQoQ means Quarter-over-Quarter. It compares the latest quarter with the immediately previous quarter to show short-term momentum changes. |
|---|---|---|---|
| RevenueThe total money that came through the front door from selling things, before paying a single bill. Think of it as the grand total of every credit card swipe from customers. (YoY compares this year to last year's performance, while QoQ compares the current three months to the previous three). | $8.3B | -0.4% | +1.4% |
| Net IncomeThe absolute bottom line. If the company paid every single supplier, employee, banker, and tax collector, this is the actual money left in their pocket at the end of the day. | $229.3M | -71.0% | -30.7% |
| Gross MarginThe basic markup. If they sell a $100 pair of sneakers, this percentage tells you how much of that price tag is profit right after paying for the rubber and shoelaces, but before paying for things like store rent or TV commercials. | +26.4% | -10.4% | -19.9% |
| Operating MarginThe 'day job' efficiency score. Out of every dollar a customer spends, this shows how many cents the company keeps after making the product AND paying for all the everyday corporate overhead (like salaries, marketing, and keeping the lights on). | +12.3% | -7.4% | +10.2% |
| Net MarginThe final take-home percentage. When you strip away every conceivable cost, tax, and interest payment, this is the exact number of cents the company truly gets to keep from every dollar in sales. | +2.8% | -70.9% | -31.7% |
| Free Cash FlowThe holy grail of corporate cash. It's the spendable, physical money left over after the business pays for its daily operations AND buys the big, expensive upgrades (like new factories or servers) it needs to survive. This is the 'free' money they can use to pay dividends or buy back stock. | — | — | +72.7% |
| FCF MarginThe ultimate cash conversion rate. It shows how good the company is at turning regular sales directly into cold, hard, spendable cash. A high percentage means the business is an absolute cash-printing machine. | — | — | +70.3% |
| Debt / EquityThe financial risk gauge. It compares how much of the company's empire was built using borrowed money (loans) versus the owners' own money (shareholders). A high number means they are heavily leveraged and playing a riskier game; a low number means they are playing it safe. | 38.7% | +2.2% | -1.2% |
| Current RatioThe 12-month survival check. It simply compares the cash they have right now (plus things they can quickly turn into cash) against the immediate bills they absolutely must pay this year. A score above 1 means they have enough in the wallet to cover the upcoming bills without panicking. | 1.10x | -13.2% | -16.3% |
| Total AssetsThe absolute size of the company's empire. It bundles together absolutely everything of value they own—from the cash in the register and the inventory in the warehouse, to the software patents in the vault and the factories on the ground. | $16.3B | -3.6% | +0.5% |
| Metric | Annual (A vs E) | Annual Surprise | Quarter (A vs E) | Quarter Surprise |
|---|---|---|---|---|
| EPS Surprise | 2.90 vs 12.88 | -77.5% | 0.94 vs 3.02 | -68.9% |
| Revenue Surprise | $8.3B vs $8.0B | +2.7% | $2.1B vs $2.1B | -1.8% |
| Date | Executive | Title | Security | Side | Shares | Price |
|---|---|---|---|---|---|---|
| Aug 11, 2026 | Whitaker Anne Clem | director | Ordinary Shares | D | 88 | $162.72 |
| Aug 11, 2026 | Whitaker Anne Clem | director | Ordinary Shares | D | 96 | $163.77 |
| Aug 11, 2026 | Whitaker Anne Clem | director | Ordinary Shares | D | 590 | $164.47 |
| Aug 11, 2026 | Whitaker Anne Clem | director | Ordinary Shares | D | 67 | $165.51 |
| Aug 11, 2026 | O'Neill Julie | director | Ordinary Shares | D | 95 | $162.72 |
Operator: Good day, and thank you for standing by. Welcome to the ICON plc Q1 2026 Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker today, Kate Haven, VP of Investor Relations. Please go ahead. Kate Haven: Hello, and thank you for joining us today. I'm joined on the call by our CEO, Barry Balfe; and our CFO, Nigel Clerkin. I would like to note that this call is webcast and that there are slides available to download on our website to accompany today's call. Certain statements in today's call will be forward-looking statements. These statements are based on management's current expectations and information currently available, including current economic and industry conditions. Actual results may differ materially from those stated or implied by forward-looking statements due to risks and uncertainties associated with the company's business, and listeners are cautioned that forward-looking statements are not guarantees of future performance. Forward-looking statements are only as of the date they are made, and we do not undertake any obligation to update publicly any forward-looking statements, either as a result of new information, future events or otherwise. More information about the risks and uncertainties relating to these forward-looking statements may be found in the most recently filed annual report on Form 20-F. This presentation includes selected non-GAAP financial measures, which Barry and Nigel will be referencing in their prepared remarks. For a presentation of the most directly comparable GAAP financial measures, please refer to the section of the press release dated June 23, 2026, titled Consolidated Statements of Operations. While non-GAAP financial measures are not superior to or a substitute for the comparable GAAP measures, we believe certain non-GAAP information is more useful to investors for historical comparison purposes. Included in the press release and the earnings slides, you will note a reconciliation of the non-GAAP measures. Adjusted EBITDA, adjusted net income and adjusted diluted earnings per share exclude amortization, stock-based compensation, foreign currency gains and losses, restructuring transaction, integration-related and other adjustments, transaction-related financing costs, fair value movement on investments in equity, goodwill impairment, impairment of nonfinancial assets and the related taxation effect. In the interest of time, we ask participants to keep their questions to one. I would now like to hand over the call to our CEO, Barry Balfe. Barry Balfe: Thank you, Kate. ICON's results in quarter 1 were in line with our expectations and reflected sustained progress in commercial performance alongside the expected impacts of previous demand and conversion dynamics on financial results for the quarter. Commercial excellence has been a central priority for me and for the team. …
| Name | Title | Compensation | Gender | Year Born | Status |
|---|---|---|---|---|---|
Steve Empoliti | Chief Commercial Officer | USD 2,512,000 | Male | — | Active |
Barry Balfe | Chief Executive Officer & Director | USD 985,000 | Male | 1979 | Active |
Nigel Clerkin | Chief Financial Officer | USD 741,000 | Male | 1974 | Active |
John Climax | Founder & Independent Non-Executive Director | USD 100,000 | — | 1953 | Active |
Thomas N. O'Leary | Chief Information Officer | — | Male | — | Active |
Niamh Murphy | Director of Corporate Communications | — | Female | — | Active |
David Green | Vice President of Marketing | — | Male | — | Active |
Diarmaid Cunningham | Chief Administrative Officer, General Counsel & Company Secretary | — | Male | 1975 | Active |
Joe Cronin | Chief Human Resources Officer | — | Male | — | Active |
Lyons Emer | Chief Accounting Officer | — | — | — | Active |
ICLR's discounted valuation and $23.4B backlog support upside potential, but falling estimates, weaker margins and execution risks argue for patience.
DUBLIN--(BUSINESS WIRE)--ICON Announces Pricing of USD 2.15 Billion Notes.
ICON's 33.2% rally is backed by stronger proposal flow, bookings and backlog, but weaker earnings and margins cloud the recovery.
DUBLIN--(BUSINESS WIRE)--ICON plc (NASDAQ: ICLR) (“ICON”), a world-leading clinical research organization, announced today that its wholly-owned subsidiary, ICON Investments Six Designated Activity Company (the “Issuer”), intends to offer one or more series of senior notes (the “Notes”), in a private offering (the “Offering”) with registration rights, subject to market and other conditions. The Notes will be guaranteed on a senior unsecured basis by ICON.
Avidity Partners Management LP lowered its stake in Icon Plc (NASDAQ: ICLR) by 51.7% during the undefined quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 16,000 shares of the medical research company's stock after selling 17,100 shares during the period. Icon makes up about 0.4%
